Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (6): 549-553.doi: 10.35541/cjd.20190931
• Reviews • Previous Articles Next Articles
Cao Shan, Yang Baoqi
Received:
2019-09-24
Revised:
2020-07-10
Online:
2021-06-15
Published:
2021-05-31
Contact:
Yang Baoqi
E-mail:baoqiyang@126.com
Cao Shan, Yang Baoqi. Dermatitis herpetiformis[J]. Chinese Journal of Dermatology, 2021, 54(6): 549-553.doi:10.35541/cjd.20190931
[1] | Bolotin D, Petronic⁃Rosic V. Dermatitis herpetiformis. Part I. Epidemiology, pathogenesis, and clinical presentation[J]. J Am Acad Dermatol, 2011,64(6):1017⁃1024; quiz 1025⁃1026. doi: 10.1016/j.jaad.2010.09.777. |
[2] | Antiga E, Maglie R, Quintarelli L, et al. Dermatitis herpetiformis: novel perspectives[J]. Front Immunol, 2019,10:1290. doi: 10. 3389/fimmu.2019.01290. |
[3] | Salmi TT. Dermatitis herpetiformis[J]. Clin Exp Dermatol, 2019,44(7):728⁃731. doi: 10.1111/ced.13992. |
[4] | West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population⁃based study[J]. Am J Gastroenterol, 2014,109(5):757⁃768. doi: 10.1038/ajg.2014.55. |
[5] | Collin P, Salmi TT, Hervonen K, et al. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease[J]. Ann Med, 2017,49(1):23⁃31. doi: 10.1080/07853890.2016.1222450. |
[6] | Hofmann SC, Nashan D, Bruckner⁃Tuderman L. Petechiae on the fingertips as presenting symptom of dermatitis herpetiformis Duhring[J]. J Eur Acad Dermatol Venereol, 2009,23(6):732⁃733. doi: 10.1111/j.1468⁃3083.2009.03200.x. |
[7] | Kern M, Kim KH, Johnson G, et al. Dermatitis herpetiformis presenting as pseudovasculitis[J]. JAAD Case Rep, 2017,3(5):444⁃447. doi: 10.1016/j.jdcr.2017.06.033. |
[8] | Stephan F, Haber R, Maalouf D, et al. A case of dermatitis herpetiformis after a mini⁃gastric bypass surgery[J]. J Am Acad Dermatol, 2014,71(1):e18⁃20. doi: 10.1016/j.jaad.2014.01.854. |
[9] | Hervonen K, Karell K, Holopainen P, et al. Concordance of dermatitis herpetiformis and celiac disease in monozygous twins[J]. J Invest Dermatol, 2000,115(6):990⁃993. doi: 10.1046/j. 1523⁃1747.2000.00172.x. |
[10] | Spurkland A, Ingvarsson G, Falk ES, et al. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA⁃DQ (alpha 1*0501, beta 1*02) or the HLA⁃DQ (alpha 1*03, beta 1*0302) heterodimers[J]. Tissue Antigens, 1997,49(1):29⁃34. doi: 10.1111/j.1399⁃0039.1997.tb02706.x. |
[11] | Sun Y, Lin Y, Yang B, et al. The HLA alleles B*0801 and DRB1*0301 are associated with dermatitis herpetiformis in a Chinese population[J]. J Invest Dermatol, 2016,136(2):530⁃532. doi: 10.1016/j.jid.2015.10.057. |
[12] | Reunala T, Salmi TT, Hervonen K. Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten⁃free diet[J]. Acta Derm Venereol, 2015,95(8):917⁃922. doi: 10.2340/00015555⁃2162. |
[13] | Lebwohl B, Sanders DS, Green PH. Coeliac disease and dermatitis herpetiformis ⁃ Authors′ reply[J]. Lancet, 2018,392(10151):917. doi: 10.1016/S0140⁃6736(18)31894⁃4. |
[14] | Bonciani D, Quintarelli L, Del Bianco E, et al. Serum levels and tissue expression of interleukin⁃31 in dermatitis herpetiformis and bullous pemphigoid[J]. J Dermatol Sci, 2017,87(2):210⁃212. doi: 10.1016/j.jdermsci.2017.04.008. |
[15] | Antiga E, Quaglino P, Pierini I, et al. Regulatory T cells as well as IL⁃10 are reduced in the skin of patients with dermatitis herpetiformis[J]. J Dermatol Sci, 2015,77(1):54⁃62. doi: 10. 1016/j.jdermsci.2014.11.003. |
[16] | Kho ZY, Lal SK. The Human gut microbiome ⁃ a potential controller of wellness and disease[J]. Front Microbiol, 2018,9:1835. doi: 10.3389/fmicb.2018.01835. |
[17] | Chibbar R, Dieleman LA. The gut microbiota in celiac disease and probiotics[J]. Nutrients, 2019,11(10):2375. doi: 10.3390/nu11102375. |
[18] | Jimenez A, Hull C, Zone J. Dermatitis herpetiformis resistant to dapsone due to dietary iodide ingestion[J]. JAAD Case Rep, 2019,5(8):713⁃714. doi: 10.1016/j.jdcr.2019.06.011. |
[19] | Barnadas MA. Dermatitis herpetiformis: a review of direct immunofluorescence findings[J]. Am J Dermatopathol, 2016,38(4):283⁃288. doi: 10.1097/DAD.0000000000000420. |
[20] | Makino T, Shimizu T. Fibrillar⁃type dermatitis herpetiformis[J]. Eur J Dermatol, 2019,29(2):115⁃120. doi: 10.1684/ejd.2019. 3533. |
[21] | Saito M, Böer A, Ishiko A, et al. Atypical dermatitis herpetiformis: a Japanese case that presented with initial lesions mimicking prurigo pigmentosa[J]. Clin Exp Dermatol, 2006,31(2):290⁃291. doi: 10.1111/j.1365⁃2230.2005.02009.x. |
[22] | 李志量, 靳培英, 冯素英. 疱疹样皮炎的血清学研究进展[J]. 国际皮肤性病学杂志, 2014,40(1):32⁃35. doi: 10.3760/cma.j.issn.1673⁃4173.2014.01.012. |
[23] | Velikova T, Shahid M, Ivanova⁃Todorova E, et al. Celiac⁃related autoantibodies and IL⁃17A in bulgarian patients with dermatitis herpetiformis: a cross⁃sectional study[J]. Medicina (Kaunas), 2019,55(5):136. doi: 10.3390/medicina55050136. |
[24] | Dahlbom I, Korponay⁃Szabó IR, Kovács JB, et al. Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase[J]. J Pediatr Gastroenterol Nutr, 2010,50(2):140⁃146. doi: 10.1097/MPG.0b013e3181a81384. |
[25] | Bijelić B, Matić IZ, Besu I, et al. Celiac disease⁃specific and inflammatory bowel disease⁃related antibodies in patients with recurrent aphthous stomatitis[J]. Immunobiology, 2019,224(1):75⁃79. doi: 10.1016/j.imbio.2018.10.006. |
[26] | Kasperkiewicz M, Dähnrich C, Probst C, et al. Novel assay for detecting celiac disease⁃associated autoantibodies in dermatitis herpetiformis using deamidated gliadin⁃analogous fusion peptides[J]. J Am Acad Dermatol, 2012,66(4):583⁃588. doi: 10.1016/j.jaad.2011.02.025. |
[27] | Al⁃Toma A, Volta U, Auricchio R, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten⁃related disorders[J]. United European Gastroenterol J, 2019,7(5):583⁃613. doi: 10.1177/20506406198 44125. |
[28] | Mansikka E, Hervonen K, Salmi TT, et al. The decreasing prevalence of severe villous atrophy in dermatitis herpetiformis: a 45⁃year experience in 393 patients[J]. J Clin Gastroenterol, 2017,51(3):235⁃239. doi: 10.1097/MCG.0000000 000000533. |
[29] | Caproni M, Antiga E, Melani L, et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis[J]. J Eur Acad Dermatol Venereol, 2009,23(6):633⁃638. doi: 10.1111/j. 1468⁃3083.2009.03188.x. |
[30] | Cinats AK, Parsons LM, Haber RM. Facial involvement in dermatitis herpetiformis: a case report and review of the literature[J]. J Cutan Med Surg, 2019,23(1):35⁃37. doi: 10. 1177/1203475418795818. |
[31] | Macrae F. Enzyme therapy that can digest the toxic motifs of gluten as an aid in the management of celiac disease[J]. Inter J Celiac Dis, 2018,6(1):4⁃6. doi: 10.12691/ijcd⁃6⁃1⁃3. |
[32] | Görög A, Németh K, Szabó L, et al. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis[J]. J Dermatol Sci, 2016,84(1):17⁃23. doi: 10.1016/j.jdermsci.2016.07.005. |
[33] | Liu H, Wang Z, Bao F, et al. Evaluation of prospective HLA⁃B*13:01 screening to prevent dapsone hypersensitivity syndrome in patients with leprosy[J]. JAMA Dermatol, 2019,155(6):666⁃672. doi: 10.1001/jamadermatol.2018.5360. |
[34] | Wang Y, Yang B, Zhou G, et al. Two cases of dermatitis herpetiformis successfully treated with tetracycline and niacinamide[J]. Acta Dermatovenerol Croat, 2018,26(3):273⁃275. |
[35] | Albers LN, Zone JJ, Stoff BK, et al. Rituximab treatment for recalcitrant dermatitis herpetiformis[J]. JAMA Dermatol, 2017,153(3):315⁃318. doi: 10.1001/jamadermatol.2016.4676. |
[36] | Mansikka E, Hervonen K, Kaukinen K, et al. Prognosis of dermatitis herpetiformis patients with and without villous atrophy at diagnosis[J/OL]. Nutrients, 2018,10(5):641 [2020⁃07⁃16]. https://www.mdpi.com/2072⁃6643/10/5/641/html. doi: 10.3390/nu10050641. |
[37] | Hervonen K, Alakoski A, Salmi TT, et al. Reduced mortality in dermatitis herpetiformis: a population⁃based study of 476 patients[J]. Br J Dermatol, 2012,167(6):1331⁃1337. doi: 10. 1111/j.1365⁃2133.2012.11105.x. |
[1] | Zhang Ning, Li Shu, Li Jing . Efficacy of immune checkpoint inhibitors and targeted therapy in adjuvant treatment of resectable melanoma: a network meta-analysis [J]. Chinese Journal of Dermatology, 2022, 0(4): 20200767-e20200767. |
[2] | Liu Yuzhen, Zeng Rong, Zheng Nana, Duan Zhimin, Xu Haoxiang, Wu Qiuju, Lin Tong, Li Min. Effect of different incubation time of aminolevulinic acid on photodynamic inhibition of Propionibacterium acnes biofilms [J]. Chinese Journal of Dermatology, 2022, 55(3): 208-212. |
[3] | Writing committee expert group on “diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement (2022) [J]. Chinese Journal of Dermatology, 2022, 55(3): 187-195. |
[4] | Lyu Ling, Lyu Xiaoyan. Dermatomyositis with malignancy: an update [J]. Chinese Journal of Dermatology, 2022, 55(3): 276-279. |
[5] | Li Suo, Xiang Ruiyu, Li Zhiliang, Jing Ke, Wang Yuan, Zhang Hanmei, Feng Suying. Evaluation of the value of indirect immunofluorescence on salt-split skin in the diagnosis of bullous pemphigoid [J]. Chinese Journal of Dermatology, 2022, 55(3): 235-237. |
[6] | Bao Shijie, Cheng Yang, Yan Ying, Fan Fang, Gao Tingting, Feng Xiaolan, Zheng Liang, Lei Wei, Huang Qinsi, Zhang Weiming, Zhou Xiaoyong. A comparative study of human immunoglobulin versus recombinant human tumor necrosis factor-α receptor Ⅱ:IgG Fc fusion protein in the treatment of toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2022, 55(2): 153-156. |
[7] | Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210694-e20210694. |
[8] | Jiao Xiaoyan, Yin Guangwen, Yin Yakun, Li Dongqin. Clinical analysis of 25 cases of herpes zoster during pregnancy or the perinatal period [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210384-e20210384. |
[9] | Li Sai, Xue Huazhong, Zhang Shuwen, Jiang Juan, Qi Shuzhen, Zhao Yuanyuan, Zhang Jinping, Sha Zhong, Le Wenjing, Wang Biwei, Zhao Shixuan, Zhu Xiaofeng, Su Xiaohong. Doxycycline-moxifloxacin sequential therapy for Mycoplasma genitalium urethritis/cervicitis: a clinical observation [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210631-e20210631. |
[10] | Ou Min, Yan Yunling, Zheng Baoqing, Wang Xiaohua. Correlations between psoriasis and obesity [J]. Chinese Journal of Dermatology, 2022, 55(2): 181-184. |
[11] | Luan Chao, Hu Yu, Chen Kun, Zhang Jiaan, Gu Heng, Zhang Ronglin, Zhang Xiaohua, Tian Panpan, Zhu Yan, Zhuang Chen, Huang Dan, Ju Mei. Efficacy and safety of 308-nm SQ light-emitting diode light and 308-nm excimer light in the treatment of facial vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2022, 55(1): 16-19. |
[12] | Wang Yuan, Yu Meiwen, Xiang Ruiyu, Li Suo, Li Zhiliang, Jin Ke, Zhang Hanmei, Feng Suying. Optimization of indirect immunofluorescence on salt-split skin and its application in detection of bullous pemphigoid antibodies [J]. Chinese Journal of Dermatology, 2022, 55(1): 12-15. |
[13] | Zhang Ying, Gan Lu, Li Siqi, Li Yan, Song Hao, Shao Xuebao, Zhang Wei, Xu Xiulian, Jiang Yiqun, Zeng Xuesi, Chen Hao, Sun Jianfang. Clinicopathological and immunophenotypic analysis of 24 cases of transformed mycosis fungoides [J]. Chinese Journal of Dermatology, 2022, 55(1): 20-26. |
[14] | Chinese Society of Dermatology, China Dermatologist Association. Consensus on the diagnosis and treatment of autoimmune subepidermal bullous diseases (2022) [J]. Chinese Journal of Dermatology, 2022, 55(1): 1-11. |
[15] | Cheng Bihong, Dou Xia. Diagnosis and classification of chronic prurigo [J]. Chinese Journal of Dermatology, 2022, 0(1): 20210130-e20210130. |
|